NDC 66992-955

Phrenilin Forte

Butalbital, Acetaminophen, Caffeine

Phrenilin Forte is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Wraser Llc. The primary component is Butalbital; Acetaminophen; Caffeine.

Product ID66992-955_109b9af7-e798-46d3-997c-5df01c73212b
NDC66992-955
Product TypeHuman Prescription Drug
Proprietary NamePhrenilin Forte
Generic NameButalbital, Acetaminophen, Caffeine
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date2017-09-18
Marketing CategoryANDA / ANDA
Application NumberANDA206615
Labeler NameWraser LLC
Substance NameBUTALBITAL; ACETAMINOPHEN; CAFFEINE
Active Ingredient Strength50 mg/1; mg/1; mg/1
Pharm ClassesCentral Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE],Barbiturates [CS],Barbiturate [EPC]
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 66992-955-10

100 CAPSULE in 1 BOTTLE (66992-955-10)
Marketing Start Date2017-09-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 66992-955-10 [66992095510]

Phrenilin Forte CAPSULE
Marketing CategoryANDA
Application NumberANDA206615
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2017-09-18
Marketing End Date2019-10-22

Drug Details

Active Ingredients

IngredientStrength
BUTALBITAL50 mg/1

OpenFDA Data

SPL SET ID:d8f3608b-814d-4f73-a64a-f60f59231a55
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1945479
  • 889520
  • UPC Code
  • 0366992955101
  • Pharmacological Class

    • Central Nervous System Stimulant [EPC]
    • Methylxanthine [EPC]
    • Xanthines [CS]
    • Central Nervous System Stimulation [PE]
    • Barbiturates [CS]
    • Barbiturate [EPC]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.